These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 38594621)
1. Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers. Lane RM; Darreh-Shori T; Junge C; Li D; Yang Q; Edwards AL; Graham DL; Moore K; Mummery CJ BMC Neurol; 2024 Apr; 24(1):116. PubMed ID: 38594621 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease. Darreh-Shori T; Siawesh M; Mousavi M; Andreasen N; Nordberg A J Alzheimers Dis; 2012; 28(2):443-58. PubMed ID: 22012848 [TBL] [Abstract][Full Text] [Related]
3. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects. De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J; J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841 [TBL] [Abstract][Full Text] [Related]
4. Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome. Bejanin A; Iulita MF; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernandez S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Padilla C; Aranha MR; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Zetterberg H; Blennow K; Alcolea D; Clarimon J; Zaman SH; Blesa R; Lleó A; Fortea J JAMA Neurol; 2021 Aug; 78(8):937-947. PubMed ID: 34228042 [TBL] [Abstract][Full Text] [Related]
5. Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients. Hiltunen M; Mannermaa A; Helisalmi S; Koivisto A; Lehtovirta M; Ryynänen M; Riekkinen P; Soininen H Neurosci Lett; 1998 Jun; 250(1):69-71. PubMed ID: 9696068 [TBL] [Abstract][Full Text] [Related]
6. No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease. Ki CS; Na DL; Kim JW; Kim HJ; Kim DK; Yoon BK Am J Med Genet; 1999 Apr; 88(2):113-5. PubMed ID: 10206226 [TBL] [Abstract][Full Text] [Related]
7. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Lehmann DJ; Johnston C; Smith AD Hum Mol Genet; 1997 Oct; 6(11):1933-6. PubMed ID: 9302273 [TBL] [Abstract][Full Text] [Related]
8. Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease. Wiebusch H; Poirier J; Sévigny P; Schappert K Hum Genet; 1999 Feb; 104(2):158-63. PubMed ID: 10190327 [TBL] [Abstract][Full Text] [Related]
9. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study. Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307 [TBL] [Abstract][Full Text] [Related]
10. Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patients. Gabriel AJ; Almeida MR; Ribeiro MH; Durães J; Tábuas-Pereira M; Pinheiro AC; Pascoal R; Santana I; Baldeiras I Neurosci Lett; 2017 Feb; 641():101-106. PubMed ID: 28108398 [TBL] [Abstract][Full Text] [Related]
11. Analysis of association between Alzheimer disease and the K variant of butyrylcholinesterase (BCHE-K). Grubber JM; Saunders AM; Crane-Gatherum AR; Scott WK; Martin ER; Haynes CS; Conneally PM; Small GW; Roses AD; Haines JL; Pericak-Vance MA Neurosci Lett; 1999 Jul; 269(2):115-9. PubMed ID: 10430518 [TBL] [Abstract][Full Text] [Related]
12. Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease. Yoo HB; Lee HW; Shin S; Park SW; Choi JS; Jung HY; Cha J; Lee JM; Lee JY Curr Alzheimer Res; 2014 Feb; 11(2):137-44. PubMed ID: 24479631 [TBL] [Abstract][Full Text] [Related]
13. Butyrylcholinesterase K variant and Alzheimer's disease risk: a meta-analysis. Wang Z; Jiang Y; Wang X; Du Y; Xiao D; Deng Y; Wang J Med Sci Monit; 2015 May; 21():1408-13. PubMed ID: 25978873 [TBL] [Abstract][Full Text] [Related]
14. Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease. Vijayaraghavan S; Darreh-Shori T; Rongve A; Berge G; Sando SB; White LR; Auestad BH; Witoelar A; Andreassen OA; Ulstein ID; Aarsland D J Alzheimers Dis; 2016; 50(2):567-76. PubMed ID: 26757188 [TBL] [Abstract][Full Text] [Related]
15. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques. Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353 [TBL] [Abstract][Full Text] [Related]
16. Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease. Gabriel AJ; Almeida MR; Ribeiro MH; Carneiro D; Valério D; Pinheiro AC; Pascoal R; Santana I; Baldeiras I J Alzheimers Dis; 2018; 61(3):1097-1105. PubMed ID: 29254094 [TBL] [Abstract][Full Text] [Related]
17. Butyrylcholinesterase K variant and cerebral amyloid angiopathy. Yamada M; Sodeyama N; Itoh Y; Suematsu N; Otomo E; Matsushita M; Mizusawa H Stroke; 1998 Dec; 29(12):2488-90. PubMed ID: 9836756 [TBL] [Abstract][Full Text] [Related]
18. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls. Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805 [TBL] [Abstract][Full Text] [Related]
19. No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease. Singleton AB; Smith G; Gibson AM; Woodward R; Perry RH; Ince PG; Edwardson JA; Morris CM Hum Mol Genet; 1998 May; 7(5):937-9. PubMed ID: 9536100 [TBL] [Abstract][Full Text] [Related]